Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kazuo Minematsu is active.

Publication


Featured researches published by Kazuo Minematsu.


Archive | 1995

Thrombolytic Therapy in Acute Ischemic Stroke III

Takenori Yamaguchi; Etsuro Mori; Kazuo Minematsu; Gregory J. del Zoppo

By reading, you can know the knowledge and things more, not only about what you get from people to people. Book will be more trusted. As this thrombolytic therapy in acute ischemic stroke iii, it will really give you the good idea to be successful. It is not only for you to be success in certain life you can be successful in everything. The success can be started by knowing the basic knowledge and do actions.


Hypertension Research | 2014

CHADS2 and CHA2DS2-VASc scores as bleeding risk indices for patients with atrial fibrillation: the Bleeding with Antithrombotic Therapy Study.

Kazunori Toyoda; Masahiro Yasaka; Shinichiro Uchiyama; Kazunori Iwade; Yukihiro Koretsune; Ken Nagata; Tomohiro Sakamoto; Takehiko Nagao; Masahiro Yamamoto; Jun Gotoh; Jun Takahashi; Kazuo Minematsu; Koichi Toyoda; A Tokunaga; A Takebayashi; M Yasaka; Masanao Yamamoto; Tetsuhiko Nagao; T Sakamoto; K Iwade; Keiichi Nagata; J Gotoh; Y Koretsune; Juro Takahashi; T Ochi; T Umemoto; T Nakazato; Mie Shimizu; M Okamoto; Hisanori Shinohara

The CHADS2 and CHA2DS2-VASc scores, that is, ischemic stroke risk indices for patients having atrial fibrillation (AF), may also be useful as bleeding risk indices. Japanese patients with AF, who routinely took oral antithrombotic agents were enrolled from a prospective, multicenter study. The CHADS2 and CHA2DS2-VASc scores were assessed based on information at entry. Scores of 0, 1 and ⩾2 were defined as the low, intermediate and high ischemic risk categories, respectively, for each index. Of 1221 patients, 873 took warfarin, 114 took antiplatelet agents and 234 took both. The annual incidence of ischemic stroke was 0.76% in the low-risk category, 1.46% in the intermediate-risk category and 2.90% in the high-risk category by CHADS2 scores, and 1.44, 0.42 and 2.50%, respectively, by CHA2DS2-VASc scores. The annual incidence of major bleeding in each category was 1.52, 2.19 and 2.25% by CHADS2, and 1.44, 1.69 and 2.24% by CHA2DS2-VASc. After multivariate adjustment, the CHADS2 was associated with ischemia (odds ratio 1.76, 95% confidence interval 1.03–3.38 per 1−category increase) and the CHA2DS2-VASc tended to be associated with ischemia (2.18, 0.89–8.43). On the other hand, associations of the indices with bleeding were weak. In conclusion, bleeding risk increased gradually as the CHADS2 and CHA2DS2-VASc scores increased in Japanese antithrombotic users, although the statistical impact was rather weak compared with their predictive power for ischemic stroke.


Archive | 2016

A Web-Based Stroke Education Application for Older Elementary Schoolchildren Focusing on the FAST Message

Shoko Tani; Hiroshi Narazaki; Yuta Ueda; Yuji Nakamura; Tenyu Hino; Satoshi Ohyama; Shinya Tomari; Chiaki Yokota; Naoki Ohboshi; Kazuo Minematsu; Kazuo Nakazawa

It is necessary to identify the symptoms of a transient ischemic attack (TIA) quickly and provide treatment at special medical facilities to prevent stroke. All family members need to learn stroke signs. Specialists are spreading the face, arm, speech, time (FAST) message for identifying typical TIA symptoms to teens as part of stroke education activity in schools. To support these activities, we developed stroke education for older elementary schoolchildren outside of a school environment using information and communication technology. We utilized HTML5 and JavaScript to make a web-based application using on the FAST message. We provided an example of our application program at an event held at the National Cerebral and Cardiovascular Center in Japan, 2014. On average, 83 % of older children answered questions about the FAST message correctly. Our application might be useful as a stroke education support tool.


Archive | 2002

Brain ischemia and spreading depression in a primate model

Chiaki Yokota; Yuji Kuge; Masafumi Tagaya; Yasuhiro Hasegawa; Takeo Abumiya; Go Kito; Takenori Yamaguchi; Kazuo Minematsu

In order to investigate the pathophysiology of ischemic stroke, we developed a primate thromboembolic stroke model and examined serial changes in cerebral blood flow (CBF) and cerebral metabolic rate of glucose (CMRglc) using positron emission tomography (PET). In addition, we attempted to elicit spreading depression (SD), which is essential in the evolution of infarcts in small animal models, by chemical stimulation in primates.


Archive | 1988

Bordering Zone Hyperemia and Glucose Metabolism in Experimental Cerebral Ischemia

Junichiro Choki; Yasuhiro Hasegawa; Kazuo Minematsu; Takenori Yamaguchi

Areas of increased blood flow (hyperemia) at the periphery of ischemic foci have been noted in experimental animals [1]. Experiments using 14C-2-deoxyglucose (2-D G) for the measurement of local cerebral glucose utilization (LCGU) have also demonstrated increased uptake of 2-DG in the bordering zone of focal ischemia [2]. The present study was designed to elucidate the relationship between hyperemia and increased 2-DG uptake in gerbils with unilateral common carotid artery (CCA) occlusion.


American Journal of Neuroradiology | 2002

Relationship between Findings of Conventional and Contrast-Enhanced Transcranial Color-Coded Real-Time Sonography and Angiography in Patients with Basilar Artery Occlusion

Masatoshi Koga; Kazumi Kimura; Kazuo Minematsu; Takenori Yamaguchi


Archive | 2001

Stroke syndromes: Putaminal hemorrhages

Kazuo Minematsu; Takenori Yamaguchi


Archive | 1995

Is Thrombolysis Useful for Acute Stroke Patients? The Experience of the MAST-I Study

Takenori Yamaguchi; Etsuro Mori; Kazuo Minematsu; Gregory J. del Zoppo


/data/revues/00029378/v208i1sS/S0002937812019291/ | 2012

680: Maternal outcomes in stroke during pregnancy and puerperium

Shinji Katsuragi; Reiko Neki; Kaoru Yamanaka; Chizuko Kamiya; Takekazu Miyoshi; Yoshinari Kobayashi; Chinami Horiuchi; Rieko Suzuki; Kazunori Toyoda; Koji Iihara; Kazuo Minematsu; Tomoaki Ikeda; Jun Yoshimatsu


脳卒中 | 2008

Efficacy and limitation of intravenous rt-PA therapy for hyperacute ischemic stroke

Takahiro Nakashima; Kazunori Toyoda; Masatoshi Koga; Hideki Matsuoka; Kazuyuki Nagatsuka; Hiroaki Naritomi; Kazuo Minematsu

Collaboration


Dive into the Kazuo Minematsu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazunori Toyoda

St. Marianna University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Atsushi Shiraishi

Tokyo Medical and Dental University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge